11/26
11:45 am
iobt
IO Biotech Announces Participation in Upcoming December Investor Conferences [Yahoo! Finance]
Low
Report
IO Biotech Announces Participation in Upcoming December Investor Conferences [Yahoo! Finance]
11/26
10:46 am
iobt
IO Biotech Announces Participation in Upcoming December Investor Conferences
Low
Report
IO Biotech Announces Participation in Upcoming December Investor Conferences
11/23
02:11 am
iobt
Low
Report
11/19
01:13 pm
iobt
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why [Yahoo! Finance]
Low
Report
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why [Yahoo! Finance]
11/14
08:36 am
iobt
IO Biotech GAAP EPS of -$0.13 beats by $0.25 [Seeking Alpha]
Medium
Report
IO Biotech GAAP EPS of -$0.13 beats by $0.25 [Seeking Alpha]
11/14
08:11 am
iobt
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
Medium
Report
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
11/14
08:05 am
iobt
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Low
Report
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
11/12
01:26 pm
iobt
IO Biotech (NASDAQ:IOBT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
IO Biotech (NASDAQ:IOBT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
08:30 am
iobt
IO Biotech Announces Participation in Upcoming Investor Conferences
Medium
Report
IO Biotech Announces Participation in Upcoming Investor Conferences
11/7
09:00 am
iobt
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Medium
Report
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
10/22
10:01 am
iobt
IO Biotech (NASDAQ:IOBT) was given a new $3.00 price target on by analysts at Piper Sandler.
High
Report
IO Biotech (NASDAQ:IOBT) was given a new $3.00 price target on by analysts at Piper Sandler.
10/20
02:30 am
iobt
IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
High
Report
IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
10/14
12:15 pm
iobt
IO Biotech (NASDAQ:IOBT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
IO Biotech (NASDAQ:IOBT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/30
09:25 am
iobt
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
Medium
Report
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
9/30
09:25 am
iobt
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $0.39 price target on the stock.
Medium
Report
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $0.39 price target on the stock.
9/30
07:03 am
iobt
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Cowen Inc to a "hold" rating.
Low
Report
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Cowen Inc to a "hold" rating.
9/23
09:00 am
iobt
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025 [Yahoo! Finance]
Low
Report
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025 [Yahoo! Finance]
9/23
08:05 am
iobt
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
Medium
Report
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
9/15
08:30 am
iobt
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
Medium
Report
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth